CO4820432A1 - Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina - Google Patents

Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina

Info

Publication number
CO4820432A1
CO4820432A1 CO97017245A CO97017245A CO4820432A1 CO 4820432 A1 CO4820432 A1 CO 4820432A1 CO 97017245 A CO97017245 A CO 97017245A CO 97017245 A CO97017245 A CO 97017245A CO 4820432 A1 CO4820432 A1 CO 4820432A1
Authority
CO
Colombia
Prior art keywords
phenylpropanolamine
phenylephrine
pseudoe
fedrine
difenilmetil
Prior art date
Application number
CO97017245A
Other languages
English (en)
Inventor
De Venne Herman Van
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24521774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4820432(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of CO4820432A1 publication Critical patent/CO4820432A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica que comprende una cantidadterapéuticamente eficaz de una mezcla consistente esencialmente en: (i) compuesto seleccionado de pseudoefedrina, fenilpropanolamina y fenilefrina, un isómero óptico individual o una sal farmacéuticamente aceptable de la misma, y (ii) al menos un compuesto seleccionado del ácido 2-(4-(difenilmetil)-1-piperacinil)-acético o derivado amídico, un isomero óptico individual o una sal farmacéuticamente aceptable del mismo. Una composición según la reivindicación 1, en donde el ácido 2-(4-(difenilmetil)-1-piperacinil)- acético o derivado amídico es un compuesto que tiene la fórmula: en donde Y es un grupo hidroxilo o un grupo -NH2 , X y X´ representan independientemente un átomo de hidrógeno, un átomo de halógeno, un radical alcoxi inferior de cadena lineal o ramificada o un radical trifluorometilo, m es 1 ó 2, y n es 1 ó 2.
CO97017245A 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina CO4820432A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,144 US6469009B1 (en) 1996-04-08 1996-04-08 Pharmaceutical compositions for the treatment of rhinitis

Publications (1)

Publication Number Publication Date
CO4820432A1 true CO4820432A1 (es) 1999-07-28

Family

ID=24521774

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97017245A CO4820432A1 (es) 1996-04-08 1997-04-04 Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina

Country Status (10)

Country Link
US (2) US6469009B1 (es)
AU (1) AU723364B2 (es)
BR (1) BR9701686A (es)
CO (1) CO4820432A1 (es)
GB (1) GB2311940B (es)
GT (1) GT199700037A (es)
NZ (1) NZ314521A (es)
PA (1) PA8426801A1 (es)
PE (1) PE42598A1 (es)
SV (1) SV1997000026A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
IL159287A0 (en) * 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
US7403981B2 (en) * 2002-01-04 2008-07-22 Quicksilver Technology, Inc. Apparatus and method for adaptive multimedia reception and transmission in communication environments
CN1652792A (zh) * 2002-03-13 2005-08-10 阵列生物制药公司 作为mek抑制剂的n3烷基化苯并咪唑衍生物
WO2004000823A1 (en) * 2002-06-21 2003-12-31 Dr. Reddy's Laboratories Limited Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride)
ATE386526T1 (de) * 2002-07-02 2008-03-15 Ucb Farchim Sa Diarylmethylpiperazines als prophylaktische oder therapeutische mittel gegen virale myocarditis
JP4303925B2 (ja) * 2002-08-19 2009-07-29 篠田プラズマ株式会社 金属酸化膜の形成方法及びガス放電管の２次電子放出膜形成方法
DE60322577D1 (de) * 2002-12-06 2008-09-11 Ucb Farchim Sa Tablette enthaltend efletirizin und pseudoephedrin
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
WO2007141743A2 (en) * 2006-06-06 2007-12-13 Ranbaxy Laboratories Limited A tablet dosage form comprising cetirizine and pseudoephedrine
ES2452822T3 (es) 2006-06-28 2014-04-02 Amgen Inc. Inhibidores del transportador 1 de glicina
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
CA2748783A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5057427A (en) 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
AU7992091A (en) * 1990-05-21 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. The use of phenylpropanolamine as a mucus secretogogue in the upper airways
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
ATE170749T1 (de) 1992-09-24 1998-09-15 Sepracor Inc Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma
WO1994006430A1 (en) 1992-09-24 1994-03-31 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
WO1994008551A2 (en) 1992-10-09 1994-04-28 The Procter & Gamble Company Pharmaceutical compositions and methods for treating cold symptoms
CA2161217A1 (en) 1993-04-30 1994-11-10 Carmelita Macklin Russell Coated pharmaceutical compositions
WO1995007103A1 (en) 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
PA8426801A1 (es) 2000-05-24
GB2311940B (en) 2000-07-19
PE42598A1 (es) 1998-08-17
NZ314521A (en) 1999-09-29
US20010020023A1 (en) 2001-09-06
BR9701686A (pt) 1998-11-10
GT199700037A (es) 1998-09-26
GB2311940A (en) 1997-10-15
AU1774097A (en) 1997-10-16
AU723364B2 (en) 2000-08-24
US6489329B2 (en) 2002-12-03
MX9702532A (es) 1998-06-30
SV1997000026A (es) 1998-11-10
GB9706842D0 (en) 1997-05-21
US6469009B1 (en) 2002-10-22

Similar Documents

Publication Publication Date Title
CO4820432A1 (es) Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
ATE297203T1 (de) Antithrombotische mitteln
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
UY25322A1 (es) Compuestos de tiourea y benzamida,composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis
ATE306261T1 (de) Antithrombosemittel
BR0010555A (pt) Inibidores de neuraminidases
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
CO5011115A1 (es) Compuestos y metodos quimioquina
UY24409A1 (es) Inhibidores de la matriz metaloproteasa
ATE272633T1 (de) Aromatische amiden
AR034556A1 (es) Un derivado de fenilalanina, una composicion farmaceutica que comprende al derivado de fenilalanina, el uso del derivado y proceso para preparar dicho derivado
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
DK0654041T3 (da) Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyre-derivater som anto-inflammatoriske midler
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
AR008234A1 (es) Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamento
ATE289991T1 (de) Substituierte beta-alaninen
DE69512208T2 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DK0699198T3 (da) N-benzoylmethyl-substituerede paroxetinderivater
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
BR9813775A (pt) Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular.
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
ECSP972074A (es) Composiciones farmaceuticas para el tratamiento de rinitis